Combination therapy led to complete remission in more than 50% of mice with different tumor types, many of which were resistant to ICB therapy alone.

Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule ...

Researchers identified biallelic variants in RNU2-2 as the cause of a recessive neurodevelopmental disorder marked by ...

Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule ...

We explore what allosteric modulators are, their benefits and drawbacks, and which candidates are currently advancing through ...

Researchers showed that chronic colitis leaves a long-lasting epigenetic memory in colonic stem cells, persisting for more than 100 days after recovery in mice. This memory is marked by durable ...

MIT Technology Review discovered that the stealth startup’s founder John Schloendorn also pitched a startling, medically ...

A metabolic enzyme found in the support cells surrounding tumors may hold the key to predicting which cancer patients will ...

In recent decades, the zebrafish has become one of the most valuable model organisms in scientific research. For a variety of ...

New research from Washington University School of Medicine in St. Louis adds to growing evidence that helping brain cells ...

Yami Gautam recently impressed at an Amazon Prime event in Mumbai, opting for a simple yet elegant yellow saree from Mishru.

Background Penetrance of breast cancer (BC) among women who carry pathogenic variants (PVs) in BRCA1 is incomplete, and the ...